Winston Kung - 21 Sep 2022 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
21 Sep 2022
Net transactions value
$0
Form type
3
Filing time
22 Sep 2022, 17:54:08 UTC
Previous filing
21 Apr 2022
Next filing
30 Jan 2023

No securities are beneficially owned.